Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Inventory (2022 - 2026)

HeartSciences filings provide 5 years of Inventory readings, the most recent being $657285.0 for Q1 2026.

  • On a quarterly basis, Inventory rose 0.79% to $657285.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $657285.0, a 0.79% increase, with the full-year FY2025 number at $650267.0, up 3.35% from a year prior.
  • Inventory hit $657285.0 in Q1 2026 for HeartSciences, roughly flat from $657285.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $677669.0 in Q3 2022 to a low of $629179.0 in Q2 2024.
  • Median Inventory over the past 5 years was $663781.5 (2024), compared with a mean of $662239.8.
  • Biggest five-year swings in Inventory: fell 6.98% in 2024 and later grew 3.35% in 2025.
  • HeartSciences' Inventory stood at $677669.0 in 2022, then fell by 0.42% to $674839.0 in 2023, then decreased by 3.25% to $652907.0 in 2024, then rose by 0.67% to $657285.0 in 2025, then changed by 0.0% to $657285.0 in 2026.
  • The last three reported values for Inventory were $657285.0 (Q1 2026), $657285.0 (Q4 2025), and $649507.0 (Q3 2025) per Business Quant data.